In the present study, we confirmed that NDRG2 can be modified by SUMO1 in lung adenocarcinoma cells and that NDRG2 SUMOylation increases the protein's ability to inhibit lung cancer tumorigenesis. The gene discussed is NDRG2; the disease is lung cancer.